These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 34364882)
1. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma. Che X; Liu M; Li D; Li Z; Guo J; Jia R Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882 [TBL] [Abstract][Full Text] [Related]
2. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation. Yu Q; Du Y; Wang S; Zheng X J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092 [TBL] [Abstract][Full Text] [Related]
3. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling. Liu J; Jiang X; Zou A; Mai Z; Huang Z; Sun L; Zhao J Cancer Res; 2021 Jan; 81(2):344-355. PubMed ID: 33203701 [TBL] [Abstract][Full Text] [Related]
4. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5. Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243 [TBL] [Abstract][Full Text] [Related]
5. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
6. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma. Zhu X; Du J; Gu Z Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775 [TBL] [Abstract][Full Text] [Related]
7. Function of miR‑152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c‑MET. Li M; Li Z; Wang X; Wang Y; Zhao C; Wang L Oncol Rep; 2018 Mar; 39(3):1173-1180. PubMed ID: 29286169 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma. Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406 [TBL] [Abstract][Full Text] [Related]
10. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells. Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772 [TBL] [Abstract][Full Text] [Related]
11. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related]
12. MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway. Jia B; Zhang S; Wu S; Zhu Q; Li W IUBMB Life; 2021 Jan; 73(1):264-272. PubMed ID: 33326690 [TBL] [Abstract][Full Text] [Related]
13. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma. Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539 [TBL] [Abstract][Full Text] [Related]
14. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression. Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454 [TBL] [Abstract][Full Text] [Related]
15. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Liu Z; Li H; Fan S; Lin H; Lian W Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566 [TBL] [Abstract][Full Text] [Related]
16. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression. Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma. Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248 [TBL] [Abstract][Full Text] [Related]
18. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma. Zhou LL; Ni J; Feng WT; Yao R; Yue S; Zhu YN; Tang HY; Lv LY; Feng JF; Zhu WG Exp Cell Res; 2017 Dec; 361(1):126-134. PubMed ID: 29024700 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. Tan J; Xiang L; Xu G IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930 [TBL] [Abstract][Full Text] [Related]
20. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma. Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]